2015 Accomplishments Report
Welcome to the 2015 Accomplishments Report of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), where we are working to create a cancer-free world, one person, one discovery at a time by integrating groundbreaking research with personalized patient care and excellence in education.
2015 was filled with notable achievements, but two things stand out:
Completing our first full year in the new James Cancer Hospital and Solove Research Institute that opened in December 2014, and earning from the National Cancer Institute a perfect score of 10 and the institute’s highest rating, “exceptional,” following a site review that led to our redesignation as a comprehensive cancer center.
Earning that designation while acclimating to our transformational cancer hospital was a remarkable achievement stemming from the dedication of our world-class faculty, staff and volunteers. We adapted quickly to our state-of-the-art facility—one of the most advanced cancer hospitals in the world—and continued to provide the science-based and compassionate care for which we are so widely known.
This Accomplishments Report highlights our achievements and activities of 2015, including:
- Peer-reviewed research studies that were published in prestigious scientific journals and have helped advance knowledge about this disease;
- Large grants that our medical scientists received for cancer research;
- Our success in recruiting some of the most brilliant minds in cancer research and care to Ohio State;
- Prominent awards earned by our medical scientists, administrators and programs;
- Far-reaching initiatives such as co-anchoring the Oncology Research Information Exchange Network (ORIEN) and launching a free “Introduction to the Science of Cancer” online course to encourage a global commitment to cancer prevention;
- The continuing success of Pelotonia, an annual grassroots bicycle tour that in 2015 raised a record $23,659,675 and boosted the event’s overall seven-year funding total to over $106 million for cancer research at the OSUCCC – James.
With more than 300 multidisciplinary cancer researchers and a new cancer hospital that brings researchers and clinicians into closer working proximity than ever before, the OSUCCC – James is superbly positioned to change the landscape of cancer care in Ohio and beyond. This report reflects our efforts toward that end.
Michael A. Caligiuri, MD
Director, The Ohio State University
Comprehensive Cancer Center
CEO, James Cancer Hospital and
Solove Research Institute
John L. Marakas Nationwide Insurance Enterprise
Foundation Chair in Cancer Research